Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment
Open Access
Abstract
Cancers are the leading cause of death, causing around 10 million deaths annually by 2020. The most common cancers are those affecting the breast, lungs, colon, and rectum. However, it has been noted that cancer metastasis is more lethal than just cancer incidence and accounts for more than 90% of cancer deaths. Thus, early detection and prevention of cancer metastasis have the capability to save millions of lives. Finding novel biomarkers and targets for screening, determination of prognosis, targeted therapies, etc., are ways of doing so. In this review, we propose various sialyltransferases and neuraminidases as potential therapeutic targets for the treatment of the most common cancers, along with a few rare ones, on the basis of existing experimental and in silico data. This compilation of available cancer studies aiming at sialyltransferases and neuraminidases will serve as a guide for scientists and researchers working on possible targets for various cancers and will also provide data about the existing drugs which inhibit the action of these enzymes.Keywords
Funding Information
- Department of Biotechnology, Government of India
This publication has 159 references indexed in Scilit:
- MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genesOncogenesis, 2013
- Sialic acid metabolism and sialyltransferases: natural functions and applicationsApplied Microbiology and Biotechnology, 2012
- NEU1 Sialidase Expressed in Human Airway Epithelia Regulates Epidermal Growth Factor Receptor (EGFR) and MUC1 Protein SignalingJournal of Biological Chemistry, 2012
- Enhancement of metastatic ability by ectopic expression of ST6GalNAcI on a gastric cancer cell line in a mouse modelClinical & Experimental Metastasis, 2012
- Sialylation of the Fas Death Receptor by ST6Gal-I Provides Protection against Fas-mediated Apoptosis in Colon Carcinoma CellsJournal of Biological Chemistry, 2011
- Overexpression of ST6GalNAcV, a ganglioside-specific α2,6-sialyltransferase, inhibits glioma growth in vivoProceedings of the National Academy of Sciences, 2010
- Over-expression of ST3Gal-I promotes mammary tumorigenesisGlycobiology, 2010
- Advances in the Biology and Chemistry of Sialic AcidsACS Chemical Biology, 2009
- Sialic acids in human health and diseaseTrends in Molecular Medicine, 2008
- CMP substitutions preferentially inhibit polysialic acid synthesisGlycobiology, 2007